Literature DB >> 9008522

HIV infection and cognition in intravenous drug users: long-term follow-up.

O A Selnes1, N Galai, J C McArthur, S Cohn, W Royal, D Esposito, D Vlahov.   

Abstract

A cohort of 185 HIV-infected injection drug users (IDUs) and seronegative controls was followed with semiannual neuropsychological assessments for up to 4.5 years. Changes in cognitive performance over time were evaluated, and results of seronegative controls were used to adjust for level of education and practice effects. The effects of duration of follow-up, decline in CD4+ count, development of clinical symptoms, antiretroviral use, and diagnosis of AIDS on changes in neuropsychological performance over time were assessed with regression models using the generalized estimating equation approach. Improvement in performance over time, consistent with practice effects, was observed for all measures. The only subtest for which the magnitude of the practice effects was mildly attenuated relative to the seronegative controls was Grooved Pegboard, dominant hand. After adjusting for disease progression and antiretroviral therapy use, none of the time trends for the neuropsychological test scores were significant, suggesting no decline in performance of the seropositive patients relative to the seronegative controls. With development of clinical symptoms, there was a trend in the direction of declining performance. For subjects reporting two or more symptoms but not using antiretroviral therapy, the trend was not significant, whereas having two or more symptoms and using antiretroviral therapy was associated with significantly worse performance on tests of psychomotor speed and memory. With development of AIDS, a significant decline in performance was observed on measures of motor and psychomotor speed as well as memory. There is thus no evidence to suggest that HIV infection in the context of chronic drug and alcohol use significantly alters the frequency or rate of progression of cognitive symptoms. These findings suggest that the natural history of cognitive changes secondary to HIV infection is similar among HIV-infected IDUs and other risk groups such as homosexual/bisexual men.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9008522     DOI: 10.1212/wnl.48.1.223

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

1.  Acceleration of HIV dementia with methamphetamine and cocaine.

Authors:  A Nath; W F Maragos; M J Avison; F A Schmitt; J R Berger
Journal:  J Neurovirol       Date:  2001-02       Impact factor: 2.643

Review 2.  HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse.

Authors:  Kurt F Hauser; Nazira El-Hage; Anne Stiene-Martin; William F Maragos; Avindra Nath; Yuri Persidsky; David J Volsky; Pamela E Knapp
Journal:  J Neurochem       Date:  2006-12-01       Impact factor: 5.372

3.  SIV/macaque model of HIV infection in cocaine users: minimal effects of cocaine on behavior, virus replication, and CNS inflammation.

Authors:  Michael Weed; Robert J Adams; Robert D Hienz; Kelly A Meulendyke; Michael E Linde; Janice E Clements; Joseph L Mankowski; M Christine Zink
Journal:  J Neuroimmune Pharmacol       Date:  2011-05-28       Impact factor: 4.147

4.  Neurocognitive impact of substance use in HIV infection.

Authors:  Desiree A Byrd; Robert P Fellows; Susan Morgello; Donald Franklin; Robert K Heaton; Reena Deutsch; J Hampton Atkinson; David B Clifford; Ann C Collier; Christina M Marra; Benjamin Gelman; J Allen McCutchan; Nichole A Duarte; David M Simpson; Justin McArthur; Igor Grant
Journal:  J Acquir Immune Defic Syndr       Date:  2011-10-01       Impact factor: 3.731

5.  Relationship between sex hormones and cognitive performance in men with substance use.

Authors:  Mihail F Zilbermint; Amy B Wisniewski; Xiaoqiang Xu; Ola A Selnes; Adrian S Dobs
Journal:  Drug Alcohol Depend       Date:  2012-09-26       Impact factor: 4.492

6.  Sex-based differences in neurocognitive functioning in HIV-infected young adults.

Authors:  Ruxandra Burlacu; Anya Umlauf; Anca Luca; Sara Gianella; Roxana Radoi; Simona M Ruta; Thomas D Marcotte; Luminita Ene; Cristian L Achim
Journal:  AIDS       Date:  2018-01-14       Impact factor: 4.177

7.  Neuropsychological functioning in HIV-positive African-American women with a history of drug use.

Authors:  K I Mason; A Campbell; P Hawkins; S Madhere; K Johnson; R Takushi-Chinen
Journal:  J Natl Med Assoc       Date:  1998-11       Impact factor: 1.798

8.  Isolating cognitive and neurologic HIV effects in substance-dependent, confounded cohorts: a pilot study.

Authors:  Desiree A Byrd; Jessica Robinson-Papp; Monica Rivera Mindt; Letty Mintz; Kathryn Elliott; Quenesha Lighty; Susan Morgello
Journal:  J Int Neuropsychol Soc       Date:  2013-02-28       Impact factor: 2.892

9.  Neuropscyhological Complications of HIV Disease and Substances of Abuse.

Authors:  Lisa R Norman; Anil Kumar
Journal:  Am J Infect Dis       Date:  2006

Review 10.  Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS.

Authors:  Mark J Ferris; Charles F Mactutus; Rosemarie M Booze
Journal:  Neurosci Biobehav Rev       Date:  2008-03-18       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.